Skip to main content

Digital Biomanufacturing Market Huge Opportunities And Rising Exponentially At A Rate Of 13.12% During 2022-2031



 The global digital biomanufacturing market is a huge market comprised of various software and platforms that include process analytical technologies, data analytics software, ai and IoMT solutions, predictive analytics and digital twin technologies, and others. If application is involved, we have bioprocess optimization and process analytics, biomanufacturing process automation and control, and flexible manufacturing.

The innovations of digital technologies have introduced various levels of shifts in manufacturing sectors. The digitalization waves have supported a wide range of applications, from upstream supply chain management to post-manufacturing product tracing and tracking.The global digital biomanufacturing market will be witnessing growth due to the inclusion of new technology trends. Any new market players that enter the market will have to have these technologies to compete in the market and to make a place and gain a strong hold.

The global  digital biomanufacturing market  report highlights that the market was valued at $15,768.9 million in 2021 and is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031 .

Global Digital Biomanufacturing Market, $Million, 2020, 2021, and 2031

Digital Biomanufacturing Market

Source: Expert Interviews and BIS Research Analysis

Market Segmentation

Global Digital Biomanufacturing Market (by Technology)

The global Digital Biomanufacturing market has been segmented based on the technology type into eight different segments, namely, process analytical technologies, data analytics software, AI and IoMT solutions, predictive analytics and digital twin technologies, and others.

Global Digital Biomanufacturing Market (by End-User)

The global Digital Biomanufacturing market has been segmented based on the end-users into two major segments, namely, biopharmaceutical companies and academic and research institutes.

biopharmaceutical companies account for the major share in the global digital biomanufacturing market.

Global Digital Biomanufacturing Market (by Application)

The global digital biomanufacturing market has been segmented based on product type into two major segments, namely, bioprocess optimization and process analytics, biomanufacturing process automation and control, and flexible manufacturing.

Global Digital Biomanufacturing Market (by Region)

The different regions covered under the global digital biomanufacturing market include North America, Europe, Asia-Pacific and Rest-of-the-World.

North America and Europe are two of the largest markets for digital biomanufacturing market while developing countries are expected to register strong growth in their adoption shortly.

 

Impact of COVID-19 on the Global Digital Biomanufacturing Market

The COVID-19 pandemic had thrusted the global Digital Biomanufacturing market. The impact of the global pandemic Digital Biomanufacturing market has brought in a positive impact to the market. One of the major impacts of COVID-19 on the global digital biomanufacturing was understanding the importance of automation and innovation of new technologies.

Digital Biomanufacturing Market Dynamics

Market Growth Drivers

• Rising Automation Process in Various Industries

• Rising Focus on Process Efficiency and Flexibility in Manufacturing

• Shift Toward Digitalization and Biomanufacturing in the Healthcare Industry

Market Challenges

• Lack of Technology Adoption and Awareness Leading to Low Return-of-Investments

• Lack of Data Security in Biomanufacturing Settings

Market Opportunities

• Increased Demand for Biologics


Key Market Players and Competition Synopsis

Some of the key players operating in the market include Atos SE, Agilent Technologies Inc., Danaher Corporation, Donaldson Company, Inc., Emerson Electric Co., General Electric Company, Honeywell International Inc., SAP SE, Siemens Healthineers AG, Bota Biosciences , Culture Biosciences, e-matica srl, Exponential Genomics, Inc., FabricNano, OVO Biomanufacturing, and Symphony Innovation, LLC

In the past few years, the global digital biomanufacturing market has witnessed several strategic and technological developments undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are funding activities, mergers and acquisitions (MA), partnerships, alliances, business expansions, regulatory and legal activities, and new offerings. The preferred strategy for companies has been new offerings of products followed by partnerships, alliances, and business expansions.

 

Key Questions Answered in the Global Digital Biomanufacturing Market Report

• How has COVID-19 impacted the growth of the global digital biomanufacturing market?
• What are the key regulations governing the digital biomanufacturing market in key regions?
• What technological developments are projected to have the maximum influence on the global digital biomanufacturing market?
• Who are the leading players holding significant dominance in the global digital biomanufacturing market?
• What are some of the growth opportunities which market players can capitalize on?
• What are the drivers and restraints for the global digital biomanufacturing market?
• Which region has the highest growth rate in the digital biomanufacturing market?
• Which are the fastest growing countries in terms of the global digital biomanufacturing market?
• What are the key strategies being adopted by market players in the global digital biomanufacturing market?
• Which are the emerging technologies in the global digital biomanufacturing market?

Get Free Sample Report -  https://bisresearch.com/requestsample?id=1315type=download

How This Report Can Add Value

Assuming that the reader is a developer of digital biomanufacturing technologies, they will be able to do the following:

• Understand their position as compared to some of the key players in the market
• Stay updated with novel technology integration, features, and the latest developments in the market
• Understand the impact of COVID-19 on the adoption of digital biomanufacturing technologies and the entry barriers as a result of it
• Gain insights into which regions to target globally
• Gain insights into the end-user perception concerning the adoption of digital biomanufacturing technologies
• Identify some of the key players in the market and understand their valuable contribution.

BIS Research Related Market Studies:

Next Generation Biomanufacturing Market

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Pharmacogenomics Services Market Dynamics, Competitive Landscape & Forecast to 2031

  BIS healthcare experts have found the pharmacogenomics services industry to be one of the most rapidly evolving and dynamic markets. The global  pharmacogenomics services market  is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031. The market is driven by certain factors, including increasing prevalence of infectious diseases and various types of cancer, increasing adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogenomics for drug discovery and development. Currently, the pharmacogenomics services industry is witnessing an upsurge due to the increasing prevalence of infectious diseases and various types of cancer, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogen...
Post a Comment
Read more

Global Liquid Biopsy Market is Projected to Reach $12,933 Million by 2030

 According to a new market intelligence report by BIS Research titled ‘Global Liquid Biopsy Market – Analysis and Forecast, 2020-2030’, The liquid biopsy market is projected to reach $12,933 million by 2030 from $2588.6 million in 2019, at a CAGR of 15.87% during the forecast period 2020-2030 BIS Research Report: https://bisresearch.com/industry-report/global-liquid-biopsy-market.html   This growth has been primarily attributed to the rising number of cancer cases coupled up with the growing awareness pertaining to non-invasive detection approaches, the increasing adoption of inorganic growth strategies by key players in the market, and the increasing research funding from the leading organizations such as the U.S. National Institute of Health, globally. The market is expected to grow at a significant growth rate due to opportunities such as the introduction of informatics and technological innovations for a large customer base and increasing adoption of cancer and other disea...
Post a Comment
Read more

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more